_id
691854193c536f8df2317895
Ticker
0AAJ.LSE
Name
PolyPeptide Group AG
Exchange
LSE
Address
Neuhofstrasse 24, Baar, Switzerland, 6340
Country
UK
Sector
Industry
Currency
GBP
Website
https://www.polypeptide.com
Description
PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, and India. It develops and manufactures synthetic peptides and oligonucleotides used as active pharmaceutical ingredients or intermediates in therapeutic products for pharmaceutical and biotech companies. The company offers portfolio of drug therapies for metabolic diseases, including the GLP-1. It also provides generic peptides and peptides used in cosmetics, animal health, and medical devices. PolyPeptide Group AG was founded in 1952 and is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.
Last Close
26.25
Volume
799
Current Price
26.55
Change
1.3216
Last Updated
2026-01-08T13:32:29.828Z
Image
https://logo.clearbit.com/www.polypeptide.com
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
167096000
Cost Of Revenue
153308000
Gross Profit
13788000
Operating Expenses
27511000
Operating Income
-13723000
Interest Expense
17331000
Pretax Income
-31054000
Net Income
-26539000
Eps
-0.8
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
4515000
EBITDA
4434000
Operating Margin
-8.212644228467468
Total Other Income Expense Net
-17331000
Cash
76695000
Short Term Investments
-
Receivables
57490000
Inventories
157681000
Total Current Assets
319825000
Property Plant Equipment
410567000
Total Assets
773067000
Payables
67195000
Short Term Debt
5168000
Long Term Debt
-
Total Liabilities
442082000
Equity
330985000
Bs_currency_symbol
-
Depreciation
18157000
Change In Working Capital
18351000
Cash From Operations
49656000
Capital Expenditures
48683000
Cash From Investing
-50811000
Cash From Financing
7170000
Net Change In Cash
76695000
Cf_currency_symbol
-
PE
0.1822
PB
2.6610361874405184
ROE
-8.018188135413991
ROA
-3.432949537362221
FCF
973000
Fcf Percent
0.00582299995212333
Piotroski FScore
2
Health Score
24
Deep Value Investing Score
5.5
Defensive Investing Score
6
Dividend Investing Score
3
Economic Moat Investing Score
5.3
Garp Investing Score
3
Growth Investing Score
2.5
Momentum Investing Score
3
Net Net Investing Score
3.5
Quality Investing Score
3.5
Value Investing Score
6
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
167096000
Quarters > 0 > income Statement > cost Of Revenue
153308000
Quarters > 0 > income Statement > gross Profit
13788000
Quarters > 0 > income Statement > operating Expenses
27511000
Quarters > 0 > income Statement > operating Income
-13723000
Quarters > 0 > income Statement > interest Expense
17331000
Quarters > 0 > income Statement > pretax Income
-31054000
Quarters > 0 > income Statement > net Income
-26539000
Quarters > 0 > income Statement > eps
-0.8
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
33173750
Quarters > 0 > income Statement > income Tax Expense
4515000
Quarters > 0 > income Statement > EBITDA
4434000
Quarters > 0 > income Statement > operating Margin
-8.212644228467468
Quarters > 0 > income Statement > total Other Income Expense Net
-17331000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
76695000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
57490000
Quarters > 0 > balance Sheet > inventories
157681000
Quarters > 0 > balance Sheet > total Current Assets
319825000
Quarters > 0 > balance Sheet > property Plant Equipment
410567000
Quarters > 0 > balance Sheet > total Assets
773067000
Quarters > 0 > balance Sheet > payables
67195000
Quarters > 0 > balance Sheet > short Term Debt
5168000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
442082000
Quarters > 0 > balance Sheet > equity
330985000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-26539000
Quarters > 0 > cash Flow > depreciation
18157000
Quarters > 0 > cash Flow > change In Working Capital
18351000
Quarters > 0 > cash Flow > cash From Operations
49656000
Quarters > 0 > cash Flow > capital Expenditures
48683000
Quarters > 0 > cash Flow > cash From Investing
-50811000
Quarters > 0 > cash Flow > cash From Financing
7170000
Quarters > 0 > cash Flow > net Change In Cash
76695000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.8
Quarters > 0 > ratios > PB
2.6610361874405184
Quarters > 0 > ratios > ROE
-8.018188135413991
Quarters > 0 > ratios > ROA
-3.432949537362221
Quarters > 0 > ratios > FCF
973000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.00582299995212333
Quarters > 0 > health Score
24
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
201749000
Quarters > 1 > income Statement > cost Of Revenue
174019000
Quarters > 1 > income Statement > gross Profit
27730000
Quarters > 1 > income Statement > operating Expenses
22523000
Quarters > 1 > income Statement > operating Income
5207000
Quarters > 1 > income Statement > interest Expense
13522000
Quarters > 1 > income Statement > pretax Income
-5834000
Quarters > 1 > income Statement > net Income
-8178000
Quarters > 1 > income Statement > eps
-0.24434863847791294
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
33468572
Quarters > 1 > income Statement > income Tax Expense
2344000
Quarters > 1 > income Statement > EBITDA
15407000
Quarters > 1 > income Statement > operating Margin
2.58092976916862
Quarters > 1 > income Statement > total Other Income Expense Net
-11041000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
68277000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
86260000
Quarters > 1 > balance Sheet > inventories
146351000
Quarters > 1 > balance Sheet > total Current Assets
328222000
Quarters > 1 > balance Sheet > property Plant Equipment
388989000
Quarters > 1 > balance Sheet > total Assets
756576000
Quarters > 1 > balance Sheet > payables
73256000
Quarters > 1 > balance Sheet > short Term Debt
35715000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
399332000
Quarters > 1 > balance Sheet > equity
357244000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-8178000
Quarters > 1 > cash Flow > depreciation
15789000
Quarters > 1 > cash Flow > change In Working Capital
-19815000
Quarters > 1 > cash Flow > cash From Operations
88928000
Quarters > 1 > cash Flow > capital Expenditures
57375000
Quarters > 1 > cash Flow > cash From Investing
-58796000
Quarters > 1 > cash Flow > cash From Financing
-13027000
Quarters > 1 > cash Flow > net Change In Cash
-48475000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.24434863847791294
Quarters > 1 > ratios > PB
2.4873492251794294
Quarters > 1 > ratios > ROE
-2.289191700910302
Quarters > 1 > ratios > ROA
-1.080922471767542
Quarters > 1 > ratios > FCF
31553000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.15639730556285286
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
135043000
Quarters > 2 > income Statement > cost Of Revenue
125287000
Quarters > 2 > income Statement > gross Profit
9756000
Quarters > 2 > income Statement > operating Expenses
22327000
Quarters > 2 > income Statement > operating Income
-12571000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-12311000
Quarters > 2 > income Statement > net Income
-11386000
Quarters > 2 > income Statement > eps
-0.35000000614790105
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
32531428
Quarters > 2 > income Statement > income Tax Expense
925000
Quarters > 2 > income Statement > EBITDA
2869000
Quarters > 2 > income Statement > operating Margin
-9.308886799019572
Quarters > 2 > income Statement > total Other Income Expense Net
260000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
48475000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
59139000
Quarters > 2 > balance Sheet > inventories
160008000
Quarters > 2 > balance Sheet > total Current Assets
292643000
Quarters > 2 > balance Sheet > property Plant Equipment
333985000
Quarters > 2 > balance Sheet > total Assets
664971000
Quarters > 2 > balance Sheet > payables
41584000
Quarters > 2 > balance Sheet > short Term Debt
46012000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
305054000
Quarters > 2 > balance Sheet > equity
359917000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-11386000
Quarters > 2 > cash Flow > depreciation
15440000
Quarters > 2 > cash Flow > change In Working Capital
-9004000
Quarters > 2 > cash Flow > cash From Operations
471000
Quarters > 2 > cash Flow > capital Expenditures
28376000
Quarters > 2 > cash Flow > cash From Investing
-32222000
Quarters > 2 > cash Flow > cash From Financing
-12296000
Quarters > 2 > cash Flow > net Change In Cash
48475000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.35000000614790105
Quarters > 2 > ratios > PB
2.399746089792924
Quarters > 2 > ratios > ROE
-3.1635071419243883
Quarters > 2 > ratios > ROA
-1.7122551209000092
Quarters > 2 > ratios > FCF
-27905000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.2066378857104774
Quarters > 2 > health Score
32
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
188538000
Quarters > 3 > income Statement > cost Of Revenue
181093000
Quarters > 3 > income Statement > gross Profit
7445000
Quarters > 3 > income Statement > operating Expenses
9449000
Quarters > 3 > income Statement > operating Income
-13504000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-19016000
Quarters > 3 > income Statement > net Income
-17174000
Quarters > 3 > income Statement > eps
-0.5206147558724823
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
32987924
Quarters > 3 > income Statement > income Tax Expense
-11764000
Quarters > 3 > income Statement > EBITDA
-2422000
Quarters > 3 > income Statement > operating Margin
-7.162481833900857
Quarters > 3 > income Statement > total Other Income Expense Net
-5512000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
95706000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
78777000
Quarters > 3 > balance Sheet > inventories
128507000
Quarters > 3 > balance Sheet > total Current Assets
326602000
Quarters > 3 > balance Sheet > property Plant Equipment
324105000
Quarters > 3 > balance Sheet > total Assets
689088000
Quarters > 3 > balance Sheet > payables
60906000
Quarters > 3 > balance Sheet > short Term Debt
45706000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
307863000
Quarters > 3 > balance Sheet > equity
381225000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-17174000
Quarters > 3 > cash Flow > depreciation
12365000
Quarters > 3 > cash Flow > change In Working Capital
13947000
Quarters > 3 > cash Flow > cash From Operations
84807000
Quarters > 3 > cash Flow > capital Expenditures
23808000
Quarters > 3 > cash Flow > cash From Investing
-28416000
Quarters > 3 > cash Flow > cash From Financing
31062000
Quarters > 3 > cash Flow > net Change In Cash
86721000
Quarters > 3 > cash Flow > currency_symbol
GBP
Quarters > 3 > ratios > PE
-0.5206147558724823
Quarters > 3 > ratios > PB
2.2974080456423374
Quarters > 3 > ratios > ROE
-4.504951144337334
Quarters > 3 > ratios > ROA
-2.4922796507848055
Quarters > 3 > ratios > FCF
60999000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.32353689972313276
Quarters > 3 > health Score
50
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
338688000
Annuals > 0 > income Statement > cost Of Revenue
299422000
Annuals > 0 > income Statement > gross Profit
39266000
Annuals > 0 > income Statement > operating Expenses
46630000
Annuals > 0 > income Statement > operating Income
-7364000
Annuals > 0 > income Statement > interest Expense
16749741
Annuals > 0 > income Statement > pretax Income
-18145000
Annuals > 0 > income Statement > net Income
-19564000
Annuals > 0 > income Statement > eps
-0.5930655108821034
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
32987924
Annuals > 0 > income Statement > income Tax Expense
1419000
Annuals > 0 > income Statement > EBITDA
28417000
Annuals > 0 > income Statement > operating Margin
-2.174272486772487
Annuals > 0 > income Statement > total Other Income Expense Net
-10781000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
68277000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
86260000
Annuals > 0 > balance Sheet > inventories
146351000
Annuals > 0 > balance Sheet > total Current Assets
328222000
Annuals > 0 > balance Sheet > property Plant Equipment
388989000
Annuals > 0 > balance Sheet > total Assets
756576000
Annuals > 0 > balance Sheet > payables
73256000
Annuals > 0 > balance Sheet > short Term Debt
35715000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
399332000
Annuals > 0 > balance Sheet > equity
357244000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-19564000
Annuals > 0 > cash Flow > depreciation
32714000
Annuals > 0 > cash Flow > change In Working Capital
72450000
Annuals > 0 > cash Flow > cash From Operations
89399000
Annuals > 0 > cash Flow > capital Expenditures
86968000
Annuals > 0 > cash Flow > cash From Investing
-91018000
Annuals > 0 > cash Flow > cash From Financing
-25323000
Annuals > 0 > cash Flow > net Change In Cash
-27429000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.5930655108821034
Annuals > 0 > ratios > PB
2.4516279691191456
Annuals > 0 > ratios > ROE
-5.476369092273068
Annuals > 0 > ratios > ROA
-2.5858605083957196
Annuals > 0 > ratios > FCF
2431000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.007177697467876039
Annuals > 0 > health Score
24
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
320372000
Annuals > 1 > income Statement > cost Of Revenue
315599000
Annuals > 1 > income Statement > gross Profit
4773000
Annuals > 1 > income Statement > operating Expenses
41110000
Annuals > 1 > income Statement > operating Income
-36468000
Annuals > 1 > income Statement > interest Expense
7172927
Annuals > 1 > income Statement > pretax Income
-58243000
Annuals > 1 > income Statement > net Income
-51440000
Annuals > 1 > income Statement > eps
-1.56030089784033
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
32968000
Annuals > 1 > income Statement > income Tax Expense
-6803000
Annuals > 1 > income Statement > EBITDA
-22151000
Annuals > 1 > income Statement > operating Margin
-11.383017242455646
Annuals > 1 > income Statement > total Other Income Expense Net
-21775000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
95706000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
78777000
Annuals > 1 > balance Sheet > inventories
128507000
Annuals > 1 > balance Sheet > total Current Assets
326602000
Annuals > 1 > balance Sheet > property Plant Equipment
324105000
Annuals > 1 > balance Sheet > total Assets
689088000
Annuals > 1 > balance Sheet > payables
60906000
Annuals > 1 > balance Sheet > short Term Debt
45706000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
307863000
Annuals > 1 > balance Sheet > equity
381225000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-51440000
Annuals > 1 > cash Flow > depreciation
30469000
Annuals > 1 > cash Flow > change In Working Capital
46199000
Annuals > 1 > cash Flow > cash From Operations
36485000
Annuals > 1 > cash Flow > capital Expenditures
56733000
Annuals > 1 > cash Flow > cash From Investing
-59512000
Annuals > 1 > cash Flow > cash From Financing
84547000
Annuals > 1 > cash Flow > net Change In Cash
58178000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-1.56030089784033
Annuals > 1 > ratios > PB
2.2960204603580565
Annuals > 1 > ratios > ROE
-13.493343825824644
Annuals > 1 > ratios > ROA
-7.464939165970094
Annuals > 1 > ratios > FCF
-20248000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-0.06320152822344025
Annuals > 1 > health Score
32
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
280978000
Annuals > 2 > income Statement > cost Of Revenue
228987000
Annuals > 2 > income Statement > gross Profit
51991000
Annuals > 2 > income Statement > operating Expenses
39384000
Annuals > 2 > income Statement > operating Income
12607000
Annuals > 2 > income Statement > interest Expense
3434828
Annuals > 2 > income Statement > pretax Income
7567000
Annuals > 2 > income Statement > net Income
7767000
Annuals > 2 > income Statement > eps
0.23533511802615192
Annuals > 2 > income Statement > dividends Per Share
9574590
Annuals > 2 > income Statement > shares Outstanding
33003999
Annuals > 2 > income Statement > income Tax Expense
-200000
Annuals > 2 > income Statement > EBITDA
35721000
Annuals > 2 > income Statement > operating Margin
4.486828150246638
Annuals > 2 > income Statement > total Other Income Expense Net
-5040000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
37528000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
49146000
Annuals > 2 > balance Sheet > inventories
145073000
Annuals > 2 > balance Sheet > total Current Assets
251570000
Annuals > 2 > balance Sheet > property Plant Equipment
297294000
Annuals > 2 > balance Sheet > total Assets
575782000
Annuals > 2 > balance Sheet > payables
45933000
Annuals > 2 > balance Sheet > short Term Debt
4662000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
154105000
Annuals > 2 > balance Sheet > equity
421677000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
7689571
Annuals > 2 > cash Flow > depreciation
23786486
Annuals > 2 > cash Flow > change In Working Capital
-14202985
Annuals > 2 > cash Flow > cash From Operations
5405569
Annuals > 2 > cash Flow > capital Expenditures
74350342
Annuals > 2 > cash Flow > cash From Investing
-78435000
Annuals > 2 > cash Flow > cash From Financing
-26601144
Annuals > 2 > cash Flow > net Change In Cash
-104377217
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
0.23533511802615192
Annuals > 2 > ratios > PB
2.078026957718823
Annuals > 2 > ratios > ROE
1.8419311463513541
Annuals > 2 > ratios > ROA
1.3489480393621196
Annuals > 2 > ratios > FCF
-68944773
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
-0.24537427485425906
Annuals > 2 > health Score
53
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
282126000
Annuals > 3 > income Statement > cost Of Revenue
182426000
Annuals > 3 > income Statement > gross Profit
99700000
Annuals > 3 > income Statement > operating Expenses
35535000
Annuals > 3 > income Statement > operating Income
64165000
Annuals > 3 > income Statement > interest Expense
2823000
Annuals > 3 > income Statement > pretax Income
59848000
Annuals > 3 > income Statement > net Income
47258000
Annuals > 3 > income Statement > eps
1.4711119412277425
Annuals > 3 > income Statement > dividends Per Share
9671000
Annuals > 3 > income Statement > shares Outstanding
32124000
Annuals > 3 > income Statement > income Tax Expense
12590000
Annuals > 3 > income Statement > EBITDA
83354000
Annuals > 3 > income Statement > operating Margin
22.743384161686624
Annuals > 3 > income Statement > total Other Income Expense Net
-4317000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
136303000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
67789000
Annuals > 3 > balance Sheet > inventories
113001000
Annuals > 3 > balance Sheet > total Current Assets
331606000
Annuals > 3 > balance Sheet > property Plant Equipment
235442000
Annuals > 3 > balance Sheet > total Assets
595038000
Annuals > 3 > balance Sheet > payables
28481000
Annuals > 3 > balance Sheet > short Term Debt
4203000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
173865000
Annuals > 3 > balance Sheet > equity
421173000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
47258000
Annuals > 3 > cash Flow > depreciation
18713000
Annuals > 3 > cash Flow > change In Working Capital
-29908000
Annuals > 3 > cash Flow > cash From Operations
57352000
Annuals > 3 > cash Flow > capital Expenditures
73961000
Annuals > 3 > cash Flow > cash From Investing
-80845000
Annuals > 3 > cash Flow > cash From Financing
130928000
Annuals > 3 > cash Flow > net Change In Cash
119095000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
1.4711119412277425
Annuals > 3 > ratios > PB
2.0250400666709405
Annuals > 3 > ratios > ROE
11.220567320317304
Annuals > 3 > ratios > ROA
7.942013787354757
Annuals > 3 > ratios > FCF
-16609000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
-0.058870859119684114
Annuals > 3 > health Score
68
Valuation > metrics > PE
0.1822
Valuation > metrics > PB
2.6610361874405184
Valuation > final Score
100
Valuation > verdict
49.1% Undervalued
Profitability > metrics > ROE
-8.018188135413991
Profitability > metrics > ROA
-8.297975455327132
Profitability > metrics > Net Margin
-0.1588248671422416
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.3356556943668143
Risk > metrics > Interest Coverage
-0.7918181293635682
Risk > final Score
27
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.419731078037119
Liquidity > metrics > Quick Ratio
2.240703121761121
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
32
Prev Risks > 1
45
Prev Risks > 2
45
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:52:24.216Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-12
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, and India. It develops and manufactures synthetic peptides and oligonucleotides used as active pharmaceutical ingredients or intermediates in therapeutic products for pharmaceutical and biotech companies. The company offers portfolio of drug therapies for metabolic diseases, including the GLP-1. It also provides generic peptides and peptides used in cosmetics, animal health, and medical devices. PolyPeptide Group AG was founded in 1952 and is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.
Stock Price
£0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ALSE Ventures approves stock split from Rs10 to Rs5 per share Business Recorder
Read more →Share Prices, Stock Quotes, Charts, Trade History, Share Chat, Financial News - London South East London South East
Read more →(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of PolyPeptide Group AG
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.